Merck KGaA (OTCMKTS:MKGAF) Stock Passes Below 50 Day Moving Average – Should You Sell?

Merck KGaA (OTCMKTS:MKGAFGet Free Report)’s stock price passed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $147.57 and traded as low as $144.67. Merck KGaA shares last traded at $149.75, with a volume of 249 shares.

Merck KGaA Stock Up 2.8 %

The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The firm has a 50-day moving average of $147.29 and a 200 day moving average of $166.49. The stock has a market capitalization of $19.32 billion, a price-to-earnings ratio of 22.82 and a beta of 0.96.

About Merck KGaA

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

Featured Stories

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.